Press Releases

ST. LOUIS, March 4, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that its subsidiary Centurion has received notice from the Delaware Department of Correction of the Department's intent to award two contracts to Centurion for medical and behavioral health services.  Both three-year contracts are expected to commence on

GAITHERSBURG, Md., March 4, 2020 /PRNewswire/ -- Sirnaomics Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced that the company's management will present its platform technology and discuss the potential utility of RNAi therapeutics at the

BURLINGTON, Mass., March 4, 2020 /PRNewswire/ -- Vecna Technologies, a leading provider of healthcare information technologies, announced today it has been awarded a contract to integrate i

Business Activity Index at 57.8%; New Orders Index at 63.1%; Employment Index at 55.6% TEMPE, Ariz., March 4, 2020 /PRNewswire/ -- Economic activity in the non-manufacturing sector grew in February for the 121st consecutive month, say the nation's purchasing and supply executives in the latest Non-Manufacturing ISM® Report On Bus

DALLAS, March 4, 2020 /PRNewswire/ -- Today, three Texas non-profit organizations -- North Texas Alliance to Red

CINCINNATI, March 4, 2020 /PRNewswire/ -- PatientPoint®, the trusted leader in engagement solutions committed to making every doctor-patient engagement better®, today launched

ATLANTA, March 4, 2020 /PRNewswire/ -- Jackson Healthcare®, a family of highly specialized healthcare staffing, search and technology companies, today announced tha

SAN FRANCISCO, March 4, 2020 /PRNewswire/ -- Spring is here and so are the tree and grass pollens that signal the start of allergy season. Major cities in Texas such as

CLEVELAND, March 4, 2020 /PRNewswire/ -- Hyland Healthcare, a leading global provider of connected healthcare solutions, will demonstrate how to "see

SANTA CLARA, Calif., March 4, 2020 /PRNewswire/ -- The increased production of monoclonal antibody (mAb) is posing various challenges in both upstream and downstream processes in drug manufacturing, creating an urgent need for next-generation harvest and clarification technologies and techniques. These technologies will make the process scala